Samsung Life Science Fund is Samsung Biologics’ corporate venture capital fund backing biotechnology, life sciences and pharmaceutical companies with strategic relevance to Samsung’s biopharma ecosystem. It has later-stage venture investment activity in the United States and is tied to Samsung Biologics’ Incheon, Republic of Korea base, making it most relevant for biopharma founders seeking strategic corporate capital.